This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Sevo Nutraceuticals, Inc.
New, natural cognitive supplement proven by science.
Waltham, MA (PRWEB) August 09, 2012
Sevo Nutraceuticals, Inc. today announced that its cornerstone product, PERCEPTIV™, is now available to consumers through select resellers and through http://www.thinkperceptiv.com. PERCEPTIV™ is a unique patents pending blend of six vitamins and clinically researched nutrients needed to maintain cellular health and vitality in the brain. The formula was developed based on independent clinical studies at a leading university and is the result of over 20 years of research and five published, university-directed clinical studies.
The unique formulation found in PERCEPTIV™ - Vitamin E, Folic Acid, Vitamin B12 and a Proprietary blend of N-Acetyl L-Cysteine, Acetyl L-Carnitine and S-Adenosyl Methionine (SAMe) has been shown to:
Sevo Nutraceuticals will be selling the product through select resellers – independent pharmacies and health food stores – throughout the United States. The company’s initial resellers include:
“We are excited to have a number of leading independent pharmacies partnering with us as we launch PERCEPTIV™ and we certainly recognize the value of the trusted relationships they have earned with their consumers,” said Bernie Prusaczyk, CEO of Sevo Nutraceuticals, Inc. “We know that they choose their products carefully and we are very pleased that they are focusing on PERCEPTIV™ as a product that may help their customers Think Better™.”
About Sevo Nutraceuticals, Inc.
Sevo Nutraceuticals was established in 2012 to license and market science-based nutraceuticals. Its vision is to become a market leader in highly efficacious, scientifically researched nutraceuticals that improve people's lives. The Company's mission is to build a select portfolio of high value products with clear markets which are leaders in their category.
Sevo’s cornerstone product, PERCEPTIV™ was licensed from UMass Lowell earlier in 2012 and was developed under the leadership of UMass Lowell Professor Thomas B. Shea, Director of the Center for Cellular Neurobiology and Neurodegeneration Research.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/8/prweb9779281.htm